Antibody Detection Test for SARS-CoV-2
The Affidea Diagnostic Centers Group performs antibody detection tests for SARS-CoV-2 at all the Group’s Diagnostic Centers in Greece, as well as nationwide through the External Services Department.
This is a hematological test for detecting IgG and IgM antibodies, which determines if the patient has been infected with SARS-CoV-2 and now has antibodies against the virus, or if further testing is needed.
The antibody detection test is conducted for epidemiological purposes, not for diagnostic purposes. This method is not suitable for diagnosing the disease during its acute phase.
A fundamental requirement for performing the antibody detection test is that the patient should not be febrile and should not have had any flu-like symptoms in the last 15 days.
During the blood draw, all precautionary measures are followed for both the phlebotomists and the patients. The test is optionally performed by appointment within the diagnostic units and is available to all age groups.
The results are sent within two business days from the day the blood draw is performed. To protect public health and avoid crowding, Affidea recommends the electronic transmission of results.
Antibody Detection Test for SARS-CoV-2
The Affidea Diagnostic Centers Group performs antibody detection tests for SARS-CoV-2 at all the Group’s Diagnostic Centers in Greece, as well as nationwide through the External Services Department.
This is a hematological test for detecting IgG and IgM antibodies, which determines if the patient has been infected with SARS-CoV-2 and now has antibodies against the virus, or if further testing is needed.
The antibody detection test is conducted for epidemiological purposes, not for diagnostic purposes. This method is not suitable for diagnosing the disease during its acute phase.
A fundamental requirement for performing the antibody detection test is that the patient should not be febrile and should not have had any flu-like symptoms in the last 15 days.
During the blood draw, all precautionary measures are followed for both the phlebotomists and the patients. The test is optionally performed by appointment within the diagnostic units and is available to all age groups.
The results are sent within two business days from the day the blood draw is performed. To protect public health and avoid crowding, Affidea recommends the electronic transmission of results.
- Antibody Detection Test for SARS-CoV-2
- Affidea of Athens
- Affidea Central
- Affidea Geniki Apeikonistiki
- Affidea of Ilioupoli - Private Clinic
- Affidea of Lavrio
- Affidea of Messini
- Affidea of Nea Erythrea
- Affidea of Dafni
- Affidea of Vari
- Affidea of Agia Sofia
- Affidea of Alimos
- Affidea of Chania
- Affidea of Glyfada
- Affidea of Herakleion Crete
- Affidea of Kalamata
- Affidea of Kallithea
- Affidea of Kavala
- Affidea of Kifisia
- Affidea of Kozani Imaging
- Affidea of Piraeus Biopathological
- Affidea of Sparta
- Affidea of Thessaloniki
- Affidea of Agia Paraskevi
- Affidea of Patisia - Deiktis Ygeias
- Affidea of Peristeri
